title: Akt-and CREB-mediated prostate cancer cell proliferation inhibition by Nexrutine, a Phellodendron amurense extract.
abstract: Evidence from epidemiological studies suggests that plant-based diets can reduce the risk of prostate cancer. However, very little information is available concerning the use of botanicals in preventing prostate cancer. As a first step toward developing botanicals as prostate cancer preventives, we examined the effect of Nexrutine on human prostate cancer cells. Nexrutine is a herbal extract developed from Phellodendron amurense. Phellodendron extracts have been used traditionally in Chinese medicine for hundreds of years as an antidiarrheal, astringent, and anti-inflammatory agent. The present study investigated its potential antitumor effect on human prostate cancer cells. Our results suggest that it inhibits tumor cell proliferation through apoptosis induction and inhibition of cell survival signaling. The results of the present study indicate that Nexrutine treatment 1) inhibits the proliferation of both androgen-responsive and androgen-independent human prostate cancer cells through induction of apoptosis; 2) reduces levels of pAkt, phosphorylated cAMP response-binding protein (pCREB) and CREB DNA-binding activity; and 3) induces apoptosis in prostate cancer cells stably overexpressing Bcl-2. Further, Akt kinase activity was reduced in cells treated with Nexrutine, and ectopic expression of myristoylated Akt protected from Nexrutine induced inhibition of proliferation, implicating a role for Akt signaling.
authors.affiliation: Department of Urology, University of Texas Health Science Center, San Antonio, TX 78229, USA.
authors.forename: Gretchen E
authors.initials: GE
authors.lastname: Garcia
authors.forename: Arevalo
authors.initials: A
authors.lastname: Nicole
authors.forename: Shylesh
authors.initials: S
authors.lastname: Bhaskaran
authors.forename: Ashima
authors.initials: A
authors.lastname: Gupta
authors.forename: Natasha
authors.initials: N
authors.lastname: Kyprianou
authors.forename: Addanki P
authors.initials: AP
authors.lastname: Kumar
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D017362:Cyclic AMP Response Element-Binding Protein / Q000096:biosynthesis*; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D007249:Inflammation; D008297:Male; D008516:Medicine, Chinese Traditional; D032102:Phellodendron / Q000378:metabolism*; D010766:Phosphorylation; D010936:Plant Extracts / Q000378:metabolism* / Q000494:pharmacology; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000378:metabolism*; D051057:Proto-Oncogene Proteins c-akt / Q000096:biosynthesis*
chemical_list: D000970:Antineoplastic Agents; D017362:Cyclic AMP Response Element-Binding Protein; C512605:Nexrutine; D010936:Plant Extracts; D051057:Proto-Oncogene Proteins c-akt